CALR and synovial sarcoma: Furthermore, estrogens can protect the disease progression of SS by reducing SS-related proinflammatory responses, such as IL-17, IFNγ, and autoantibodies Ro/SSA and La/SSB [20,82,144,145,146,147,148,216].